PHENERGAN VC W/ CODEINE
LOE Approachingcodeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride
NDAORALSYRUP
Approved
Jan 1952
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Phenergan VC with Codeine is an oral syrup combination product containing codeine phosphate (antitussive), phenylephrine hydrochloride (decongestant), and promethazine hydrochloride (antihistamine/anticholinergic). It is indicated for the symptomatic relief of cough and upper respiratory congestion associated with allergies, colds, and related conditions. The combination provides multi-symptom relief through suppression of cough reflex and reduction of nasal congestion and histamine-mediated symptoms.
LOE Approaching
As LOE approaches, the brand team is likely consolidating and preparing for generic entry, with focus on cost containment and stakeholder management rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Phenergan VC with Codeine at ANI Pharmaceuticals means joining a sunset-phase product team focused on efficient market exit and regulatory compliance rather than growth. Career development is best suited for professionals with expertise in product lifecycle management, generic competition, and operational efficiency in a declining revenue environment.
Regulatory Affairs Specialist
Worked on PHENERGAN VC W/ CODEINE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.